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Background: We reported that yam dioscorin and its peptic hydrolysates exhibited ACE inhibition and antihypertensive
effects on SHRs, however, the active peptides are not really isolated until now. Using ACE inhibitory screenings,
two penta-peptides, KTCGY and KRIHF, were selected for ex vivo and in vivo experiments.
Results: KTCGY, KRIHF, and captopril were shown to have similar vasodilating effects against phenylephrine
(PE)-induced tensions in rat endothelium-dependent thoracic aortic rings, however, KTCGYKTCGY (two-repeated
KTCGY) and TCGYTCGY (two-repeated TCGY) were showed endothelium-independent vasodilating effects against
PE-induced tensions. KTCGY, KRIHF (10 or 20 mg/kg), and captopril (10 mg/kg) were used to evaluate antihypertensive
activity during 24-h after a single oral administration to spontaneously hypertensive rats (SHRs). The KTCGY and KRIHF
showed significantly different and reduced the systolic blood pressure of SHRs compared to the blank.
Conclusions: These results suggest that KTCGY and KRIHF may contribute important roles in yam dioscorin for
regulating blood pressure in vivo.
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Processed yam tuber is a traditional Chinese medicine
used as a juvenescent substance, with no apparent side
effects resulting from long-term use, which is ranked the
top levels in Chinese Pharmacopoeia. Yams (Dioscorea
spp., Dioscoreaceae) are an important tuber crop in Africa,
Asia, and Middle and South America and are also a staple
food in the Caribbean. Yam dioscorin and its peptic
hydrolysates have been reported to exhibit several bio-
logical activities in vitro and in vivo (Lu et al. 2012),
including antioxidant (Hou et al. 2001; Liu et al. 2006;
Han et al. 2013, 2014a,b), antihypertensive (Hsu et al.
2002; Lin et al. 2006; Liu et al. 2009a), immunomodulatory
(Liu et al. 2007; Liu et al. 2009b), and enzyme activities
(Hou et al. 1999a, b; Hou et al. 2000).
The untreated high blood pressure is considered to be
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in any medium, provided the original work is p33% deaths (Mark and Davis 2000). There are several
classes of pharmacological agents which have been
used in the treatment of hypertension, and one class of
antihypertensive drugs known as angiotensin I converting
enzyme (ACE) inhibitors is associated with a low rate of
adverse side effects and is the preferred class of antihyper-
tensive agents when treating patients with concurrent sec-
ondary diseases or cardiovascular diseases (Zaman et al.
2002). ACE (peptidyldipeptide hydrolase, EC 3.4.15.1) is a
dipeptide-liberating Zn-containing exopeptidase, which
removes a dipeptide from the C-terminus of angiotensin I
to form angiotensin II, a very hypertensive compound.
Several ACE inhibitory peptides were isolated from food
proteins and exhibited generally to reduce blood pressures
of SHRs (Martínez-Maqueda et al. 2012). Fujita et al.
(2000) found that the octapeptides of FFGRCVSP (IC50 =
0.4 μM) and ERKIKVYL (IC50 = 1.2 μM) were potent ACE
inhibitors, but none of them were effective in spontan-
eously hypertensive rats (SHRs) to reduce the blood
pressure. These potential ACE inhibitory peptides werepen Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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and then lose their antihypertensive effects on SHR
in vivo. We reported that yam dioscorin and its peptic
hydrolysates exhibited ACE inhibitory activity (Hsu et al.
2002) and antihypertensive activity (Lin et al. 2006) using
SHRs as models, however, the active peptides are not
really isolated until now. In this study, using angiotensin
converting enzyme inhibition as preliminary screenings,
two out of twenty-three synthesized peptides from a
computer-aided simulation of pepsin hydrolysis of yam
dioscorin were selected for further ex vivo and in vivo
experiments and captopril was used for comparisons. It is
suggested that KTCGY and KRIHF show vasodilating ef-
fects and can reduce SHR’s systolic blood pressure (SBP)
which may contribute important roles in yam dioscorin
for regulating blood pressure in vivo.Methods
Materials
The 23 peptides for ACE inhibitory activity screenings
were synthesized by Mission Biotech. (Taipei, Taiwan).
Peptides for ex vivo and in vivo experiments used in
this study (KTCGY, KTCGYKTCGY, TCGYTCGY, and
KRIHF) were synthesized by Shanghai Hanhong Chemical
Co., Ltd (Shanghai, China) or Shanghai Mocell Biotech
Co., Ltd (Shanghai, China). The purity of each peptide was
determined to be greater than 97% by performing HPLC
chromatography and mass spectroscopy. Captopril was
purchased from Calbiochem Co. (CA, USA). N-(3-[2-
furyl]acryloyl]-Phe-Gly-Gly (FAPGG), ACE (I unit, rabbit
lung), dimethyl sulfoxide (DMSO) were purchased from
Sigma Chemical Co. (St. Louis, MO, USA). Other chemi-
cals and reagents were from Sigma Chemical Co. (St. Louis,
MO, USA).Computer-aided simulation of pepsin hydrolysis of
yam dioscorin
The deduced sequences of dioscorin A (UniProtKB/
TrEMBL:Q9M519) and dioscorin B (UniProtKB/TrEMBL:
Q9M501) were selected from the website of the ExPASy
SIB Bioinformatics Resource Portal (http://www.expasy.
org/proteomics) to participate in a computer-aided simu-
lation of pepsin hydrolysis (pH > 2) (http://web.expasy.
org/peptide_mass/). Twenty-three peptides were selected
for syntheses following the general rules which the peptide
contained aromatic or branched-chain aliphatic amino
acids closed to the COOH-terminus for ACE inhibitions
(Cheung et al. 1980), including (1) KTCGNGME, (2)
PPCSE, (3) CDDRVIRTPLT, (4) KTCGY, (5) PPCTE,
(6) RDNGVIF, (7) KRIHF, (8) RRDY, (9) RSVF, (10)
PTNF, (11) GISW, (12) MGSF, (13) VSIL, (14) HSPA,
(15) DPF, (16) RY, (17) RF, (18) NW, (19) RL, (20) GVI,
(21) GSL, (22) SY, and (23) GPA.ACE inhibitory assay screenings
The ACE inhibitory activity was measured following the
previous reports with some modifications (Hsu et al.
2002). Each synthesized peptide was dissolved in DMSO
to 4 mM as stocks. The 1 ml, 0.5 mM FAPGG (dissolved
in 50 mM Tris–HCl buffer, pH 7.5, containing 0.3 M
NaCl) was mixed with 12.2 μl peptide solution, and then
twenty μl (20 μU) of commercial ACE (stock solution,
1U/ ml) was added. The 0.1% DMSO solution was used
instead of sample solution for blank experiments
(ΔAblank/min). The decreased absorbance at 345 nm
(ΔAsample/min) was recorded during 90 sec at room
temperature. The ACE inhibition (%) was calculated as
followed: [1 - (ΔAsample/min ÷ ΔAblank/min)] × 100.
Effects of KTCGY, KTCGYKTCGY, TCGYTCGY, and KRIHF on
phenylephrine-induced tensions in rat thoracic aortic ring
ex vivo
Effects of four peptides and captopril on vascular tension
were examined following the previous method (Wang
et al. 2001). Male Sprague–Dawley rats were killed by
decapitation, and sections of the thoracic aorta between
the aortic arch and the diaphragm were excised carefully
and placed in a Petri dish with oxygenated Krebs’ buffer
(120 mM NaCl, 4.5 mM KCl, 2.5 mM CaCl2, 1 mM
MgSO4, 27 mM NaHCO3, 1 mM KH2PO4, 10 mM glucose,
pH 7.4, with 95% O2, 5% CO2) and gently dissected free of
fat and connective tissue. The endothelium was removed
by gently rubbing the intimal layer of the vessel with a wire.
The isolated aortic rings, 3 to 4 mm in length with or
without the endothelium, were fixed isometrically in organ
chambers under passive tension (1.8 g) for 60 min.
Changes in vascular tension were recorded with a poly-
graph (Gould, model 2400, Valley View, OH, USA) via
a force displacement transducer (Grass FT03, Quincy,
MA, USA). After equilibration, the near maximal con-
centration was induced by PE (0.3 μM). When the
rings achieved a stable tension, the acetylcholine (3 μM)
was added to the bath to assess endothelial integrity. The
relaxing effects of KTCGY, KTCGYKTCGY, TCGYTCGY,
KRIHF, and captopril on PE (0.3 μM) pre-contracted
endothelium-intact or endothelium-denuded aortic rings
were examined. When PE treatments reached a steady
plateau (considered as 100%), KTCGY, KTCGYKTCGY,
TCGYTCGY, KRIHF, and captopril were then tested at
cumulative concentrations (0.1 to 100 μM) for their ability
to induce aortic ring relaxations.
Antihypertensive Effects of KTCGY, KRIHF, and captopril
in SHRs
Experimental procedures were reviewed and approved
by the Institutional Animal Care and Use Committee of
Taipei Medical University (LAC-95-0076, LAC-97-0117,
and LAC-100-0038). Male SHRs (18–28 weeks old; from
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housed individually in steel cages kept at 24°C under a
12-h light–dark cycle, with free access to water and a
standard mouse/rat chow (Prolab® RMH2500, 5P14 Diet,
PMI Nutrition International Brentwood, MO, USA).
SHRs were randomly divided into 4 groups (N = 6 of each
group), KTCGY or KRIHF at concentration of 10 mg/kg
and 20 mg/kg was orally administered to the SHRs, and
the SBP were measured after 0, 2, 4, 6, 8, and 24 h by
using an indirect tail-cuff blood pressure meter (BP98-A,
Softron, Tokyo, Japan). Distilled water (0.5 ml) was admin-
istered to the SHRs in the blank group. The captopril
(10 mg/kg) was used as the positive control.Figure 1 ACE inhibition by 23 synthesized peptides (40 μM)
derived from a computer-aided simulation of pepsin hydrolysis
of yam dioscorin. The 0.1% DMSO solution was used instead of
sample solution for blank experiments (ΔAblank/min). The decreased
absorbance at 345 nm (ΔAsample/min) was recorded during 90 sec at
room temperature. The ACE inhibition (%) was calculated as
followed: [1 - (ΔAsample/min ÷ ΔAblank/min)] × 100. The synthesized
peptides included (1) KTCGNGME, (2) PPCSE, (3) CDDRVIRTPLT, (4)
KTCGY, (5) PPCTE, (6) RDNGVIF, (7) KRIHF, (8) RRDY, (9) RSVF, (10)
PTNF, (11) GISW, (12) MGSF, (13) VSIL, (14) HSPA, (15) DPF, (16) RY,
(17) RF, (18) NW, (19) RL, (20) GVI, (21) GSL, (22) SY, and (23) GPA.Statistical analysis
Data were expressed as mean ± S.D. For animal experi-
ments, the differences between the blank and the ex-
perimental group at the same time was analyzed using
Student’s t-test, and the P-value of less than 0.05 (*),
0.01 (**), and 0.001 (***) were recognized as different
significantly. The statistical analysis was performed
using the SigmaPlot software 10.0.Arrow indicated peptide with ACE inhibition over 50%.
Table 1 The synthesized peptides derived from
computer-aided simulation of pepsin hydrolysisa of yam
dioscorinb,c with potential angiotensin converting









4 KTCGY dioscorin B (52–56) 570.66
7 KRIHF dioscorin A (118–122) 699.85
dioscorin B (118–122)
a)PeptideMass tool in Proteomics (http://web.expasy.org/peptide_mass/) of
ExPASy: SIB Bioinformatics Resource Portal (http://www.expasy.org) website.
b)Dioscorin A from UniProtKB/TrEMBL:Q9M519;
c)Dioscorin B from UniProtKB/TrEMBL:Q9M501.Results
ACE inhibitory assay screenings
The deduced sequences of dioscorin A (UniProtKB/
TrEMBL:Q9M519) were selected for computer-aided
simulation of pepsin hydrolysis (pH > 2). There were
sixty-four peptide fragments and seven amino acid residues
(A, L, Q, E, F, Y, and W) were released from dioscorin A in
a computer-aided simulation hydrolysis (Additional file 1:
Figure S1). The deduced sequences of dioscorin B
(UniProtKB/TrEMBL:Q9M501) were selected for simula-
tion of pepsin hydrolysis (pH > 2). There were sixty-five
peptide fragments and eight amino acid residues (A, I, L,
Q, E, F, Y, and W) were released from dioscorin B in a
computer-aided simulation hydrolysis (Additional file 1:
Figure S2). Following the general rules which the peptide
contained aromatic or branched-chain aliphatic amino
acids closed to the COOH-terminus for ACE inhibitions
(Cheung et al. 1980), the twenty-three peptides were se-
lected for syntheses in order to test ACE inhibitory activ-
ity. In assay system, the substrate FAPGG was hydrolyzed
by ACE to generate FAP and dipeptide GG released, and
the absorbance at 345 nm was decreased. From the results
of Figure 1, under the same concentration of 40 μM for
each peptide, the KTCGY (No.4) and KRIHF (No. 7)
showed the first two potent ACE inhibitory peptides
among 23 synthesized peptides. The KTCGY and KRIHF
with higher than 50% ACE inhibitory activity were se-
lected for further ex vivo and in vivo antihypertensive
experiments. Table 1 showed the information of KTCGY
and KRIHF in yam dioscorin.Relaxations in rat thoracic aortic ring with or without
endothelium ex vivo
Except from two penta-peptides of KTCGY and KRIHF,
KTCGYKTCGY (two-repeated KTCGY) and TCGYTCGY
(two-repeated TCGY) were also synthesized for ex vivo
aortic ring vasodilating experiments and captopril was
used for comparisons. It was found that KTCGY,
KRIHF, and captopril showed endothelium-dependent,
but not endothelium-denuded, aortic ring relaxations
in PE-induced tensions (Figure 2A, D, and E). When
100 μM of KTCGY, KRIHF, or captopril was added, the
PE-induced aortic ring tension was markedly reduced from
100% to (26.97 ± 7.48)%, (19.19 ± 7.63)% or (26.81 ± 5.54)%,
respectively. Only KRIHF at 10 μM could reduce PE-
induced aortic ring tensions from 100% to (80.26 ± 7.82)%.
Figure 2 Vasorelaxing activity of endothelium-intact and endothelium-denuded SD rat aortic rings in phenylephrine-induced tensions.
(A) KTCGY, (B) KTCGYKTCGY, (C) TCGYTCGY, (D) KRIHF, and (E) captopril on Data were expressed as mean ± S.E.
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endothelium-independent aortic ring relaxations in
PE-induced tensions (Figure 2B and C). When 100 μM
of KTCGYKTCGY or TCGYTCGY was added, the PE-
induced endothelium-intact aortic ring tension was mark-
edly reduced from 100% to (46.05 ± 8.02)% or (43.52 ±
6.42)%, respectively; under the same 100 μM concentration,
KTCGYKTCGY or TCGYTCGY reduced the PE-induced
endothelium-denuded aortic ring tension from 100% to
(66.59 ± 14.84)% or (74.44 ± 15.13)%, respectively.
Antihypertensive activity in vivo
The KTCGY or KRIHF (10 or 20 mg/kg) was orally
administered once and the SBP was measured at 2-, 4-,
6-, 8-, and 24-h, and the captopril (10 mg/kg) was used
for comparisons. Figure 3A shows the SBP changes of
SHR after KTCGY oral administration during 24 h. It was
found that KTCGY at 10 or 20 mg/kg showed dose-
dependently antihypertensive activity by lowing SBP and
showed significantly different compared to the blank at
6-h (P < 0.01) and 8-h (P < 0.01) for 10 mg/kg and at 2-h
(P < 0.05), 4-h (P < 0.001), 6-h (P < 0.001), 8-h (P < 0.001)
for 20 mg/kg. The average reduced SBP for 10 mg/kg at
6-h and 8-h was 24.17 and 11.93 mmHg, respectively; the
average reduced SBP for 20 mg/kg at 2-h, 4-h, 6-h, and 8-h
was 24.20, 26.24, 31.03, and 21.40 mmHg, respectively.
The positive control of captopril (10 mg/kg) showedantihypertensive activity by lowing SBP and showed signifi-
cantly different compared to the blank at 2-h (P < 0.001),
4-h (P < 0.01), 6-h (P < 0.001), 8-h (P < 0.01), and 24-h
(P < 0.05). The average reduced SBP for captopril
(10 mg/kg) at 2-h, 4-h, 6-h, 8-h, and 24-h was 26.85,
24.97, 29.82, 24, and 13.80 mmHg, respectively. It was
noted that KTCGY at 20 mg/kg showed similar antihy-
pertensive activity to captopril at 10 mg/kg. Figure 3B
shows the SBP changes of SHR after KRIHF oral ad-
ministration during 24 h. It was found that KRIHF at
10 or 20 mg/kg showed dose-independently antihyper-
tensive activity by lowing SBP and showed significantly
different compared to the blank at 2-h (P < 0.05), 4-h
(P < 0.01), 6-h (P < 0.01) and 8-h (P < 0.01) for 10 mg/kg
and at 2-h (P < 0.01), 4-h (P < 0.05), 6-h (P < 0.01), 8-h
(P < 0.01) for 20 mg/kg. The KRIHF at dose of 10 and
20 mg/kg showed similar antihypertensive activities to-
ward SHRs. The average reduced SBP for 10 mg/kg at
2-h, 4-h, 6-h, and 8-h was 17.30, 21.95, 21.47, and
16.65 mmHg, respectively; the average reduced SBP for
20 mg/kg at 2-h, 4-h, 6-h, and 8-h was 18.57, 19.64,
20.87, and 8.99 mmHg, respectively.
Discussion
The present ex vivo and in vivo data showed KTCGY
and KRIHF with vasodilating effects against PE-induced
endothelium-intact aortic tensions and lowering SHR’s
Figure 3 Antihypertensive activity of (A) KTCGY and (B) KRIHF
on systolic blood pressure of spontaneously hypertensive rats
(SHRs). KTCGY or KRIHF at concentration of 10 mg/kg and 20 mg/kg
was orally administered to the SHRs (6 rats/group), and the SBP were
measured after 0, 2, 4, 6, 8, and 24 h by using an indirect tail-cuff blood
pressure meter (BP98-A, Softron, Tokyo, Japan). Distilled water (0.5 ml)
was administered to the SHRs in the blank group. The captopril
(10 mg/kg) was used as the positive control. Data were expressed as
mean ± S.D. For animal experiments, the differences between the blank
and the experimental group at the same time was analyzed using
Student’s t-test, and the P-value of less than 0.05 (*), 0.01 (**), and 0.001
(***) were recognized as different significantly.
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tion of pepsin hydrolysis of the yam tuber dioscorin.
The penta-peptide of KTCGY was positioned at amino
acid residue 52 to residue 56 of dioscorin B protein
(UniProtKB/TrEMBL:Q9M501, Fig. S2), and the penta-
peptide of KRIHF was positioned at amino acid residue
118 to residue 122 of dioscorin A protein (UniProtKB/
TrEMBL:Q9M519, Fig. S1) and dioscorin B protein
(UniProtKB/TrEMBL:Q9M501, Fig. S2). Conlan et al.
(1995) first reported two classes of cDNA clones encoding
major yam tuber storage proteins from Dioscorea caye-
nensis and named as dioscorin. We demonstrated thatdioscorins from six cultivars of three Dioscorea species
accounted over 90% of water-soluble proteins by immune
stains (Hou et al. 2000). The processed yam tuber is a
traditional Chinese medicine used as a juvenescent sub-
stance, with no apparent side effects after long-term uses;
the tuber is involved in the top levels in a famous Chinese
pharmacopoeia. It was recently reviewed that yam dios-
corin and its peptic hydrolysates exhibited several bio-
logical activities in vitro and in vivo (Lu et al. 2012). It
seems that yam or its major protein, dioscorin, may be
potentials in developments of several aspects of func-
tional food and needed further investigations.
From the present results of ACE inhibitory activity
screenings (Figure 1), the orders of top 5 among 23 syn-
thetic peptides were KTCGY (No.4) > KRIHF (No. 7) >
NW (No. 18) > RRDY (No. 8) > RY (No. 16) ≅ SY (No.
22) ≅ CDDRVIRTPLT (No. 3). These potent ACE inhibi-
tory peptides were promised to the general rules which
peptides contained aromatic or branched-chain aliphatic
amino acids closed to the COOH-terminus for ACE
inhibitions (Cheung et al. 1980). The dioscorin peptic
hydrolysates were reported to exhibit ACE inhibitory
activity (Hsu et al. 2002) and antihypertensive activity
(Lin et al. 2006) using SHR as models. Therefore, the
synthetic KTCGY and KRIHF were used for ex vivo
and in vivo experiments. KTCGY and KRIHF showed
endothelium-dependent aortic ring relaxations in PE-
induced tensions (Figure 2A, D) which the vasodilating ef-
fects were similar to ACE inhibitor, captopril (Figure 2E).
The captopril is designed to inhibit ACE, one of important
enzymes in renin-angiotensin system, to achieve antihy-
pertension (Rubin et al. 1978). It was reported that capto-
pril also showed endothelium-dependent rabbit aortic ring
relaxations in PE-induced tensions, and the possible
action mechanism might be from its superoxide radical
scavenging activity of its structural sulfhydryl group
(Mittra and Singh 1998). Hernández-Ledesma et al. (2005)
reported that individual amino acids exhibited different
oxygen radical absorbance capacity (ORAC) activities,
such as Trp [W, 4.649 μmole trolox equivalents (TE)/
μmole], Tyr (Y, 1.574 μmole TE/μmole), Met (M, 1.126
μmole TE/μmole), Cys (0.1492 μmole TE/μmole), His
(H, 0.073 μmole TE/μmole), and Phe (F, 0.0025 μmole
TE/μmole), which a Trp-indole group, Tyr-phenolic
group, His-imidazole group, and Cys-sulfhydryl group
served as hydrogen donors to contribute ORAC activity. It
was reported that the ovokinin (2–7) (a hexa-peptide,
RADHPF) isolated from chymotryptic ovalbumin hydroly-
sates exhibited dose-dependently nitric oxide-stimulated
vaso-relaxations in endothelium-intact PE-induced ten-
sions of SHR’s mesenteric artery, however, ovokinin (2–7)
showed less effect on ACE inhibition (IC50 higher than
1 mM) (Matoba et al. 1999). Therefore, we propose
that vaso-relaxing peptides of KTCGY and KRIHF in
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scavenging and nitric oxide stimulating activities and
need further investigations.
The KTCGYKTCGY and TCGYTCGY showed endothe-
lium-intact and endothelium-denuded vaso-relaxing activ-
ities in PE-induced tensions which were different from the
action mode of KTCGY of above-mentioned. The ovokinin
(an octa-peptide, FRADHPFL) isolated from peptic hydro-
lysates of egg ovalbumin showed bradykinin B1 receptor
antagonist and exhibited endothelium-independent canine
mesenteric artery relaxations in prostaglandin F2α-induced
tensions (Fujita et al. 1995). Recently, a series of experi-
ments by Matsui team demonstrated that WH di-peptide
showed endothelium-independent SD rat aortic ring
relaxations in KCl-induced contractions by suppressing
Ca2+ influx (Tanaka et al. 2008), which the inhibition of
extracellular calcium entry into vascular smooth muscle
cells by blocking dihydropyridine-like L-type Ca2+
channels (Wang et al. 2010), and the inhibition against
voltage-dependent L-type Ca2+ channels phosphorylation
(Kobayashi et al. 2012). The HRW tri-peptide also showed
endothelium-independent vaso-relaxing activities in
PE-induced tensions by inhibiting extracellular Ca2+
influx (Tanaka et al. 2009). Therefore, it is proposed that
KTCGYKTCGY and TCGYTCGY with endothelium-
independent vaso-relaxing activities in PE-induced ten-
sions might involve Ca2+ influx and Ca2+ channels and
needed investigations further.
From the present results of in vivo SHR oral administra-
tion, both penta-peptides of KTCGY and KRIHF at doses
of 10 and 20 mg/kg exhibited antihypertensive activities
by lowering SBP, but not diastolic blood pressure (data
not shown), among which KTCGY of 20 mg/kg exhibited
the similar lowering SBP profile to captopril of 10 mg/kg
after a single oral administration. However, the vaso-
relaxing peptide with antihypertensive activity is not
necessary for potent ACE inhibition. Therefore, it might
loss some antihypertensive peptides from ACE inhibitory
screenings in the present study. The RF di-peptide
(Kagebayashi et al. 2012) and IHRF tetra-peptide (Kontani
et al. 2014) isolated from rice glutelin with lower ACE
inhibition was reported to exhibit cholecystokinin-
dependent vaso-relaxing and antihypertensive activities in
SHR, which the RF di-peptide was the same as No. 17 syn-
thesized peptide in Figure 1 of less ACE inhibitory activity
in the present study from computer-aided simulation of
pepsin hydrolysis of yam dioscorin A (residues of 134–135
and 158–159) and yam dioscorin B (residues of 158–159).
However, these results provide evidences to support yam
dioscorin after ingestion for blood pressure regulations.
Conclusions
The KTCGY and KRIHF show vasodilating effects and
can reduce SHR’s systolic blood pressure which maycontribute important roles in yam dioscorin for regulating
blood pressure in vivo and will be beneficial for anti-
hypertension in functional food preparations.
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